EVIDENCE FOR CONVERSION OF 5-FLUOROCYTOSINE TO 5-FLUOROURACIL IN HUMANS - POSSIBLE FACTOR IN 5-FLUOROCYTOSINE CLINICAL TOXICITY

被引：96
作者：
DIASIO, RB
LAKINGS, DE
BENNETT, JE
机构：
[1] NCI,CHEM PHARMACOL LAB,BETHESDA,MD 20014
[2] NIAID,CLIN INVEST LAB,BETHESDA,MD 20014
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1978年 / 14卷 / 06期
关键词：
D O I：
10.1128/AAC.14.6.903
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：903 / 908
页数：6
相关论文
共 13 条
[1]   FLUCYTOSINE [J].
BENNETT, JE .
ANNALS OF INTERNAL MEDICINE, 1977, 86 (03) :319-322
[2]   PHARMACOLOGICAL STUDIES WITH 5-FLUOROCYTOSINE [J].
BLOCK, ER ;
BENNETT, JE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1972, 1 (06) :476-&
[3]  
FINN C, 1975, CANCER CHEMOTH REP 1, V59, P279
[4]  
GUDAUSKAS G, 1978, P AM ASSOC CANC RES, V19, P364
[5]  
HEIDELBERGER C, 1974, CANCER MED, P768
[6]   SENSITIVE ASSAY OF 5-FLUOROURACIL IN PLASMA BY GAS CHROMATOGRAPHY MASS SPECTROMETRY [J].
HILLCOAT, BL ;
KAWAI, M ;
MCCULLOCH, PB ;
ROSENFELD, J ;
WILLIAMS, CKO .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (01) :135-143
[7]   BONE-MARROW TOXICITY ASSOCIATED WITH 5-FLUOROCYTOSINE THERAPY [J].
KAUFFMAN, CA ;
FRAME, PT .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1977, 11 (02) :244-247
[8]   METABOLISM OF 5-FLUOROCYTOSINE-214C AND OF CYTOSINE-14C IN RAT AND DISPOSITION OF 5-FLUOROCYTOSINE-214C IN MAN [J].
KOECHLIN, BA ;
RUBIO, F ;
PALMER, S ;
GABRIEL, T ;
DUSCHINSKY, R .
BIOCHEMICAL PHARMACOLOGY, 1966, 15 (04) :435-+
[9]   QUANTITATIVE-ANALYSIS OF 5-FLUOROURACIL IN HUMAN-SERUM BY SELECTED ION MONITORING GAS CHROMATOGRAPHY-MASS SPECTROMETRY [J].
LAKINGS, DB ;
ADAMSON, RH .
JOURNAL OF CHROMATOGRAPHY, 1978, 146 (03) :512-517
[10]  
MYERS CE, 1976, CANCER TREATMENT REV, V3, P155
12